Stefan Niewiarowski
#125,396
Most Influential Person Now
Stefan Niewiarowski's AcademicInfluence.com Rankings
Stefan Niewiarowskibiology Degrees
Biology
#7896
World Rank
#10886
Historical Rank
Molecular Biology
#952
World Rank
#975
Historical Rank
Biochemistry
#1107
World Rank
#1224
Historical Rank
Download Badge
Chemistry Biology
Stefan Niewiarowski's Degrees
- PhD Biochemistry University of California, San Francisco
- Bachelors Chemistry University of California, Berkeley
Why Is Stefan Niewiarowski Influential?
(Suggest an Edit or Addition)Stefan Niewiarowski's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Disintegrins: A Family of Integrin Inhibitory Proteins from Viper Venoms (1990) (469)
- Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex. (1987) (297)
- Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test. (1970) (260)
- Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion. (1993) (222)
- Disintegrins and other naturally occurring antagonists of platelet fibrinogen receptors. (1994) (198)
- Viper Venom Disintegrins and Related Molecules (1998) (185)
- Antiheparin proteins secreted by human platelets. purification, characterization, and radioimmunoassay. (1979) (182)
- AN EVALUATION OF THE EUGLOBULIN METHOD FOR THE DETERMINATION OF FIBRINOLYSIS (1959) (177)
- Platelet function during cardiac operation: comparison of membrane and bubble oxygenators. (1982) (169)
- Exposure of fibrinogen receptor on human platelets by proteolytic enzymes. (1981) (166)
- Human neutrophil degranulation during extracorporeal circulation (1987) (165)
- Platelet interaction with polymerizing fibrin. (1972) (165)
- Trigramin: primary structure and its inhibition of von Willebrand factor binding to glycoprotein IIb/IIIa complex on human platelets. (1989) (153)
- Inhibition of human megakaryocytopoiesis in vitro by platelet factor 4 (PF4) and a synthetic COOH-terminal PF4 peptide. (1989) (151)
- Loss of platelet fibrinogen receptors during clinical cardiopulmonary bypass. (1989) (150)
- Plasmin-induced platelet aggregation and platelet release reaction. Effects on hemostasis. (1973) (146)
- Transgenic mice studies demonstrate a role for platelet factor 4 in thrombosis: dissociation between anticoagulant and antithrombotic effect of heparin. (2004) (145)
- Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass. (1996) (142)
- Laboratory identification of intravascular coagulation. The serial dilution protamine sulfate test for the detection of fibrin monomer and fibrin degradation products. (1971) (130)
- Effects of chymotrypsin and adenosine diphosphate on the exposure of fibrinogen receptors on normal human and Glanzmann's thrombasthenic platelets. (1981) (129)
- Inhibition of platelet adhesion to surfaces of extracorporeal circuits by disintegrins. RGD-containing peptides from viper venoms. (1990) (128)
- Platelet Factor 4 and Adenosine Diphosphate Release during Human Platelet Aggregation (1969) (124)
- Echicetin: a snake venom protein that inhibits binding of von Willebrand factor and alboaggregins to platelet glycoprotein Ib. (1993) (119)
- Thrombocytin, a serine protease from Bothrops atrox venom. 2. Interaction with platelets and plasma-clotting factors. (1979) (119)
- Loss of fibrinogen receptors from the platelet surface during simulated extracorporeal circulation. (1985) (111)
- Characterization of human platelet basic protein, a precursor form of low-affinity platelet factor 4 and beta-thromboglobulin. (1986) (108)
- Biochemistry of alpha granule proteins. (1985) (103)
- The Disintegrin-like Domain of the Snake Venom Metalloprotease Alternagin Inhibits α2β1 Integrin-Mediated Cell Adhesion (2000) (99)
- Significance of RGD Loop and C-Terminal Domain of Echistatin for Recognition of αIIbβ3 and αvβ3 Integrins and Expression of Ligand-Induced Binding Site (1997) (99)
- Structural Requirements of Echistatin for the Recognition of αvβ3 and α5β1Integrins* (1999) (95)
- Thrombocytin, a serine protease from Bothrops atrox venom. 1. Purification and characterization of the enzyme. (1979) (94)
- The interaction of human platelet thrombospondin with fibrinogen. Thrombospondin purification and specificity of interaction. (1985) (93)
- A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseases. (1970) (91)
- Comparison of Disintegrins with Limited Variation in the RGD Loop in Their Binding to Purified Integrins αIIbβ3, αVβ3 and α5β1 and in Cell Adhesion Inhibition (1994) (91)
- EC3, a Novel Heterodimeric Disintegrin from Echis carinatus Venom, Inhibits α4 and α5 Integrins in an RGD-independent Manner* (1999) (89)
- High molecular weight kininogen inhibits fibrinogen binding to cytoadhesins of neutrophils and platelets (1989) (84)
- Isolation and characterization of EMS16, a C-lectin type protein from Echis multisquamatus venom, a potent and selective inhibitor of the alpha2beta1 integrin. (2000) (82)
- Importance of the structure of the RGD‐containing loop in the disintegrins echistatin and eristostatin for recognition of αIIbβ3 and αvβ3 integrins (1996) (81)
- Interaction of platelet factor 4 with human platelets. (1985) (81)
- Proteins Secreted by the Platelet (1977) (80)
- Fibrinogen receptors in platelet adhesion to surfaces of extracorporeal circuit. (1987) (80)
- Studies on the Adsorption and Activation of the Hageman Factor (Factor XII) by Collagen and Elastin (1965) (80)
- Function of human platelets during extracorporeal circulation. (1977) (78)
- Inhibition of murine melanoma cell-matrix adhesion and experimental metastasis by albolabrin, an RGD-containing peptide isolated from the venom of Trimeresurus albolabris. (1991) (77)
- Preservation of Human Platelets with Prostaglandin Ei during in Vitro Simulation of Cardiopulmonary Bypass (1979) (74)
- Platelet Aggregation by ADP and Thrombin (1966) (73)
- Identification of the disulfide bond pattern in albolabrin, an RGD-containing peptide from the venom of Trimeresurus albolabris: significance for the expression of platelet aggregation inhibitory activity. (1991) (72)
- A prospective study of platelets and plasma proteolytic systems during the early stages of Rocky Mountain spotted fever. (1988) (71)
- Elegantin and albolabrin purified peptides from viper venoms: homologies with the RGDS domain of fibrinogen and von Willebrand factor. (1990) (70)
- Abnormal inside-out signal transduction-dependent activation of glycoprotein IIb-IIIa in a patient with impaired pleckstrin phosphorylation. (1996) (67)
- Trigramin, an RGD-containing peptide from snake venom, inhibits cell-substratum adhesion of human melanoma cells. (1988) (67)
- Interaction of disintegrins with the alpha IIb beta 3 receptor on resting and activated human platelets. (1994) (66)
- Inhibitory Effects of MLDG-containing Heterodimeric Disintegrins Reveal Distinct Structural Requirements for Interaction of the Integrin α9β1 with VCAM-1, Tenascin-C, and Osteopontin* (2000) (64)
- Nafamostat Mesilate, a Broad Spectrum Protease Inhibitor, Modulates Platelet, Neutrophil and Contact Activation in Simulated Extracorporeal Circulation (1996) (64)
- Structural requirements of platelet chemokines for neutrophil activation. (1994) (63)
- Platelet aggregation and exposure of fibrinogen receptors by prostaglandin endoperoxide analogues. (1983) (63)
- Batroxostatin, an Arg-Gly-Asp-containing peptide from Bothrops atrox, is a potent inhibitor of platelet aggregation and cell interaction with fibronectin. (1990) (62)
- Effects of the disintegrin eristostatin on individual steps of hematogenous metastasis. (1995) (62)
- Alboaggregins A and B. Structure and Interaction with Human Platelets (1998) (61)
- Loss of platelet alpha 2-adrenergic receptors during simulated extracorporeal circulation: prevention with prostaglandin E1. (1985) (61)
- The presence of the WGD motif in CC8 heterodimeric disintegrin increases its inhibitory effect on alphaII(b)beta3, alpha(v)beta3, and alpha5beta1 integrins. (2002) (60)
- The Disintegrin Eristostatin Interferes with Integrin α4β1 Function and with Experimental Metastasis of Human Melanoma Cells (1998) (58)
- Structural and functional characterization of EMF10, a heterodimeric disintegrin from Eristocophis macmahoni venom that selectively inhibits alpha 5 beta 1 integrin. (1999) (58)
- Effect of heparin on the in vivo release and clearance of human platelet factor 4. (1983) (57)
- Identification and separation of secreted platelet proteins by isoelectric focusing. Evidence that low-affinity platelet factor 4 is converted to beta-thromboglobulin by limited proteolysis. (1980) (56)
- Disintegrin Interaction with αvβ3Integrin on Human Umbilical Vein Endothelial Cells: Expression of Ligand-Induced Binding Site on β3Subunit (1996) (56)
- Increased platelet adhesiveness in hypertensive cardiovascular disease. (1968) (55)
- Effect of four disintegrins on the adhesive and metastatic properties of B16F10 melanoma cells in a murine model. (1995) (55)
- Human Platelet Factor 4 and Its C-Terminal Peptides: Heparin Binding and Clearance from the Circulation (1990) (55)
- Acquired granular pool defect in stored platelets. (1981) (54)
- Interaction of viper venom serine peptidases with thrombin receptors on human platelets (2000) (54)
- The disulfide bridge pattern of snake venom disintegrins, flavoridin and echistatin (1992) (53)
- Isolation, characterization and amino acid sequence of echicetin beta subunit, a specific inhibitor of von Willebrand factor and thrombin interaction with glycoprotein Ib. (1994) (53)
- Significance of the intact polypeptide chains of human fibrinogen in ADP-induced platelet aggregation (1977) (52)
- Disulphide-bond pattern and molecular modelling of the dimeric disintegrin EMF-10, a potent and selective integrin alpha5beta1 antagonist from Eristocophis macmahoni venom. (2000) (52)
- Immunological characterization of eristostatin and echistatin binding sites on alpha IIb beta 3 and alpha V beta 3 integrins. (1996) (52)
- FIBRINOGEN INTERACTION WITH PLATELET RECEPTORS * † (1983) (50)
- RGD- and MLD-disintegrins, jarastatin and EC3, activate integrin-mediated signaling modulating the human neutrophils chemotaxis, apoptosis and IL-8 gene expression. (2004) (50)
- Nonenzymatic polymerization of fibrinogen by protamine sulfate. An electron microscope study. (1969) (50)
- Affinity labeling of a human platelet membrane protein with 5'-p-fluorosulfonylbenzoyl adenosine. Concomitant inhibition of ADP-induced platelet aggregation and fibrinogen receptor exposure. (1981) (49)
- Contribution of thrombogenic factors to the pathogenesis of atherosclerosis. (1983) (49)
- Activation of Intravascular Coagulation by Collagen.∗ (1966) (49)
- Selective Recognition of α2β1 Integrin by Jararhagin, a Metalloproteinase/Disintegrin from Bothrops jararaca Venom (2001) (49)
- Inhibition of platelet hemostatic plug formation by trigramin, a novel RGD-peptide. (1989) (48)
- Secreted platelet proteins with antiheparin and mitogenic activities in chronic renal failure. (1980) (47)
- Tirofiban provides "platelet anesthesia" during cardiopulmonary bypass in baboons. (1997) (47)
- Structural requirements of echistatin for the recognition of alpha(v)beta(3) and alpha(5)beta(1) integrins. (1999) (46)
- Effect of factor Xa inhibitors on thrombin formation and complement and neutrophil activation during in vitro extracorporeal circulation. (1996) (45)
- Human neutrophil degranulation during extracorporeal circulation. (1987) (45)
- Interaction of cultured human fibroblasts with fibrin: modification by drugs and aging in vitro. (1973) (45)
- Inhibition of fibrinogen receptor-mediated platelet aggregation by heterologous anti-human platelet membrane antibody. Significance of an Mr = 66,000 protein derived from glycoprotein IIIa. (1983) (44)
- In vivo release and turnover of secreted platelet antiheparin proteins in rhesus monkey (Macaca mulatta). (1980) (44)
- Adhesion of Fibroblasts to Polymerizing Fibrin and Retraction of Fibrin Induced by Fibroblasts 1 (1972) (43)
- Formation of highly ordered polymers from fibrinogen and fibrin degradation products. (1970) (42)
- Immunoassay of human platelet factor 4(PF4, antiheparin factor) by radial immunodiffusion. (1976) (42)
- Pathological implications of cell aging in vitro. (1975) (42)
- Granulocyte-platelet interactions and platelet fibrinogen receptor exposure. (1988) (42)
- Platelet-specific α-Granule Proteins and Thrombospondin in Bronchoalveolar Lavage in the Adult Respiratory Distress Syndrome (1989) (42)
- Measurement of Platelet Microparticles during Cardiopulmonary Bypass by Means of Captured ELISA for GPIIb/IIIa (1998) (42)
- Truncated and microparticle-free soluble tissue factor bound to peripheral monocytes preferentially activate factor VII (2005) (41)
- Binding of dipyridamole to human platelets and to alpha1 acid glycoprotein and its significance for the inhibition of adenosine uptake. (1977) (40)
- Participation of Soluble Fibrin Monomer Complexes and Platelet Factor 4 in the Generalized Shwartzman Reaction (1968) (40)
- Subcellular localization of human platelet antiheparin proteins. (1979) (40)
- PLATELET INTERACTION WITH FIBRINOGEN AND FIBRIN: COMPARISON OF THE INTERACTION OF PLATELETS WITH THAT OF FIBROBLASTS, LEUKOCYTES, AND ERYTHROCYTES * (1972) (40)
- Human platelet basic protein associated with antiheparin and mitogenic activities: purification and partial characterization. (1980) (40)
- Integrilin prevents prolonged bleeding times after cardiopulmonary bypass. (1998) (39)
- The disulphide bond pattern of bitistatin, a disintegrin isolated from the venom of the viper Bitis arietans (1997) (39)
- Mouse antithrombotic assay. Inhibition of platelet thromboembolism by disintegrins. (1993) (39)
- Release of Platelet Factor 4 in Vivo during Intravascular Coagulation and in Thrombotic States (1968) (38)
- Cyclosporin A augments human platelet sensitivity to aggregating agents by increasing fibrinogen receptor availability. (1991) (37)
- Interaction of Echicetin with a High Affinity Thrombin Binding Site on Platelet Glycoprotein GPIb (1995) (36)
- Platelet factor 4--antiheparin protein releasable from platelets. Purification and properties. (1973) (36)
- Throbocytin-a novel platelet activating enzyme from Bothrops atrox venom. (1977) (36)
- Products of tissue injury. Their induction of venous endothelial damage and blood cell adhesion in the dog. (1980) (36)
- Method for Determining Antiheparin Activity of Platelets and Erythrocytes (1965) (36)
- Comparison of disintegrins with limited variation in the RGD loop in their binding to purified integrins alpha IIb beta 3, alpha V beta 3 and alpha 5 beta 1 and in cell adhesion inhibition. (1994) (35)
- Interaction of leukocytes with platelet microparticles derived from outdated platelet concentrates. (1998) (35)
- Structural and functional characterization of major platelet membrane components derived by limited proteolysis of glycoprotein IIIa. (1989) (34)
- Role of kidney in the catabolic clearance of human platelet antiheparin proteins from rat circulation. (1981) (34)
- Binding of glycoprotein IIIa-derived peptide 217-231 to fibrinogen and von Willebrand factors and its inhibition by platelet glycoprotein IIb/IIIa complex. (1992) (34)
- Thrombin and Human Plasma Kallikrein Inhibition during Simulated Extracorporeal Circulation Block Platelet and Neutrophil Activation (1998) (34)
- Antithrombin III levels during heparin therapy. (1981) (34)
- Platelet Factor 4 Efficiently Reverses Heparin Anticoagulation in the Rat Without Adverse Effects of Heparin–Protamine Complexes (1992) (33)
- A micromethod of euglobulin fibrinolysis in plasma of human subjects and small laboratory animals. (1959) (33)
- New anticoagulant derived from fibrin (1958) (32)
- Inihibition of human platelet aggregation by dipyridamole and two related compounds and its modification by acid glycoproteins of human plasma. (1975) (32)
- ADP, thrombin, and Bothrops atrox thrombinlike enzyme in platelet-dependent fibrin retraction. (1975) (32)
- Platelet interaction with polymerizing fibrin in Glanzmann's thrombasthenia. (1981) (31)
- Significance of RGD loop and C-terminal domain of echistatin for recognition of alphaIIb beta3 and alpha(v) beta3 integrins and expression of ligand-induced binding site. (1997) (31)
- Thrombogenic activity of mouse and human tumors: effects on platelets, coagulation, and fibrinolysis, and possible significance for metastases (1976) (30)
- Clearance of human platelet factor 4 by liver and kidney: its alteration by heparin. (1986) (30)
- Occurrence of platelet basic protein, a precursor of low affinity platelet factor 4 and beta-thromboglobulin, in human platelets and megakaryocytes. (1988) (29)
- A method radioimmunoassay of human platelet thrombospondin: Different patterns of thrombospondin and β-thromboglobulin antigen secretion and clearance from the circulation (1985) (29)
- Significance of the intact polypeptide chains of human fibrinogen in ADP-induced platelet aggregation. (1977) (29)
- Heparin and protease inhibitors in the prevention of experimental acute pancreatic necrosis in dogs. (1969) (28)
- Iloprost and echistatin protect platelets during simulated extracorporeal circulation. (1995) (28)
- Disintegrin interaction with alpha V beta 3 integrin on human umbilical vein endothelial cells: expression of ligand-induced binding site on beta 3 subunit. (1996) (28)
- Platelet-specific alpha-granule proteins and thrombospondin in bronchoalveolar lavage in the adult respiratory distress syndrome. (1989) (27)
- Receptor-mediated effects of a PGH2 analogue (U 46619) on human platelets. (1987) (26)
- Effect of heparin on the in vivo release and clearance of human platelet factor 4 (1983) (26)
- Release of adenine nucleotides and platelet factor 4 from platelets of man and four other species. (1970) (26)
- Platelet antiheparin proteins and antithrombin III interact with different binding sites on heparin molecule (1979) (25)
- Conversion of low-affinity platelet factor 4 to beta-thromboglobulin by plasmin and trypsin. (1980) (25)
- Increased procoagulant activity in cultured fibroblasts from progeria and Werner's syndromes of premature ageing (1976) (25)
- A double-isotope study on incorporation of platelets and red cells into fibrin. (1977) (25)
- Importance of the structure of the RGD-containing loop in the disintegrins echistatin and eristostatin for recognition of alpha IIb beta 3 and alpha v beta 3 integrins. (1996) (24)
- Disintegrins: The Naturally-Occurring Antagonists of Platelet Fibrinogen Receptor (1994) (24)
- Identification of PlAl alloantigen domain on a 66 kDa protein derived from glycoprotein IIIa of human platelets. (1985) (23)
- α1-Antitrypsin Pittsburgh (Met358 → Arg) Inhibits the Contact Pathway of Intrinsic Coagulation and Alters the Release of Human Neutrophil Elastase during Simulated Extracorporeal Circulation (1994) (23)
- Retention of Platelet Fibrin Stabilizing Factor during the Platelet Release Reaction and Clot Retraction (1973) (22)
- The disintegrin eristostatin interferes with integrin alpha 4 beta 1 function and with experimental metastasis of human melanoma cells. (1998) (22)
- Macrothrombocytic Thrombopathia. Clinical, Coagulation and Hereditary Aspects (1963) (22)
- Comparative Studies of the Fibrinolytic System of Sera of Various Vertebrates (1959) (22)
- Protection of Platelets During Long‐term Extracorporeal Membrane Oxygenation in Sheep With a Single Dose of a Disintegrin (1992) (22)
- Identification and characterization of endothelial glycoprotein Ib using viper venom proteins modulating cell adhesion. (1999) (21)
- Integrins involved in the adhesion of megakaryocytes to fibronectin and fibrinogen. (1998) (21)
- Radioimmunoassay of human platelet thrombospondin: different patterns of thrombospondin and beta-thromboglobulin antigen secretion and clearance from the circulation. (1985) (20)
- Reversal of heparin anticoagulation by recombinant platelet factor 4 and protamine sulfate in baboons during cardiopulmonary bypass. (1995) (20)
- The disintegrin-like domain of the snake venom metalloprotease alternagin inhibits alpha2beta1 integrin-mediated cell adhesion. (2000) (20)
- [Role of the contact factor (Hageman factor) in fibrinolysis]. (1959) (20)
- Exposure of Platelet Fibrinogen Receptors by Zinc Ions: Role of Protein Kinase C (1993) (19)
- Invited letter concerning: aprotinin. (1991) (19)
- DISSOCIATION OF PLATELET ANTIHEPARIN FACTOR (PLATELET FACTOR 4) FROM LIPOPROTEIN LIPASE INHIBITOR. (1964) (19)
- A baboon model for hematologic studies of cardiopulmonary bypass. (1997) (19)
- Association of fibrin with the platelet cytoskeleton. (1984) (19)
- Characterization of the cross-linking site of disintegrins albolabrin, bitistatin, echistatin, and eristostatin on isolated human platelet integrin GPIIb/IIIa. (1994) (19)
- EC3, a heterodimeric disintegrin from Echis carinatus, inhibits human and murine alpha4 integrin and attenuates lymphocyte infiltration of Langerhans islets in pancreas and salivary glands in nonobese diabetic mice. (2000) (19)
- EC3, a novel heterodimeric disintegrin from Echis carinatus venom, inhibits alpha4 and alpha5 integrins in an RGD-independent manner. (1999) (19)
- Recombinant desulfatohirudin as a substitute for heparin during cardiopulmonary bypass. (1994) (18)
- Platelet antiplasmin: its extrusion during the release reaction, subcellular localization, characterization, and relationship to antiheparin in pig platelets. (1976) (18)
- Antigenic and antiheparin properties of human platelet factor 4 (PF4) (1975) (18)
- The effect of dipyridamole on adenosine uptake by platelets ex vivo. (1977) (18)
- Zinc ions potentiate adenosine diphosphate-induced platelet aggregation by activation of protein kinase C. (1994) (18)
- Activation of Blood Clotting and Inhibition of Fibrinolysis in Acute Pancreatitis (1968) (18)
- Enoxaparin suppresses thrombin formation and activity during cardiopulmonary bypass in baboons. (1998) (17)
- Distinction between glycoprotein IIIa and the 100-kDa membrane protein (aggregin) mediating ADP-induced platelet activation. (1988) (17)
- β3 Integrin-Derived Peptide 217-230 Inhibits Fibrinogen Binding and Platelet Aggregation: Significance of RGD Sequences and Fibrinogen Aα-Chain (1993) (17)
- Inhibition of mitogenic activity of a platelet growth factor (platelet basic protein) in 3T3 cells by heparin. (1980) (17)
- Isolation, Characterization, and Immunological Detection of Neutrophil-Activating Peptide 2: A Proteolytic Degradation Product of Platelet Basic Protein (1992) (17)
- Purification of two heparin-binding proteins from porcine platelets and their homology with human secreted platelet proteins. (1983) (16)
- A natural motif approach to protein design: a synthetic leucine zipper peptide mimics the biological function of the platelet factor 4 protein (1997) (16)
- Human platelet basic protein. Its relation to low affinity platelet factor 4 and beta-thromboglobulin. (1982) (16)
- Platelet anesthesia with nitric oxide with or without eptifibatide during cardiopulmonary bypass in baboons. (1999) (16)
- Fibrinolytic System in Patients with Hypertensive Cardiovascular Disease (1967) (16)
- Abnormalities of platelet function and ultrastructure in macrothrombocytic thrombopathia. (2009) (15)
- Platelet Aggregation by Staphylococcal Toxins (1966) (14)
- The plasmin inhibition by synthetic antifibrinolytic agents in relation to the type of substrate. (1968) (14)
- Methylcellulose protects the ability of anchorage-dependent cells to adhere following isolation and holding in suspension. (1995) (14)
- Ovine platelet factor 4: purification, amino acid sequence, radioimmunoassay and comparison with platelet factor 4 of other species. (1991) (13)
- Acrylamide Gel Electrophoresis of Fibrinogen and Fibrin Degradation Products (1971) (13)
- Fibrinolytic Activity of Tissue Sections of the Dog Kidney (1964) (13)
- Identification of granular heterogeneity in blood platelets by controlled digitonin-induced cell lysis. (1980) (13)
- Influence of fibrinogen derived antithrombin (antithrombin VI) on the blood coagulation system. (1959) (12)
- Inhibition of the platelet-dependent fibrin retraction by the fibrin stabilizing factor (FSF, factor 13). (1973) (12)
- Immunological characterization of eristostatin and echistatin binding sites on αIIb β3 and αvβ3 integrins (1996) (12)
- Nomenclature of Secreted Platelet Proteins – Report of the Working Party on Secreted Platelet Proteins of the Subcommittee on Platelets (1985) (12)
- Uptake and Processing of Human Platelet Factor 4 by Hepatocytes (1987) (12)
- Fibrinolysis and Fibrinogen Breakdown Products (Antithrombin VI) in Renal Venous Blood (RVB) in Dog (1964) (12)
- Intravascular Coagulation and Fibrinolysis by Stapliylocoagiilase. Comparison with Thrombin (1965) (12)
- Comparison of platelet fibrinogen receptors on intact and proteolytically-treated platelets by use of an anti-glycoprotein IIIa monoclonal antibody (MA 123). (1984) (12)
- Integrins Involved in the Adhesion of Megakaryocytes to Fibronectin and Fibrinogen (1998) (12)
- Aggregation of chymotrypsin-treated thrombasthenic platelets is mediated by fibrinogen binding to glycoproteins IIb and IIIa. (1985) (11)
- Partial purification and characterization of porcine platelet-derived growth factor (PDGF). (1984) (11)
- Arginine Esterase Activity of the Contact (Hageman) Factor (1962) (11)
- Quantitation and characterization of human platelet glycoprotein IIIa by radioimmunoassay. (1987) (10)
- Antigenic and antiheparin properties of human platelet factor 4 (PF4). (1975) (10)
- Glycoprotein lib peptide 656–667 mimics the fibrinogen γ chain 402–411 binding site on platelet integrin GPIIb/IIIa (1993) (10)
- PEESERVATION OF PLATELETS DURING EXTRACORPOREAL CIRCULATION WITH PROSTAGLANDIN E1 (1977) (9)
- One-Step Affinity Purification of Recombinant αvβ3Integrin from Transfected Cells (1996) (9)
- Effect of dipyridamole and its monoglucuronide derivative on adenosine uptake by human platelets and ADP-induced platelet aggregation. (1977) (9)
- Aggregation of Fibrinogen and Its Degradation Products by Basic Proteins (1971) (9)
- Influence of Plasma Lipoproteins on the Fibrinolytic Activity (1967) (9)
- Identification of two distinct adenosine diphosphate receptors in human platelets. (1980) (8)
- Separation of different receptor-mediated effects of a prostaglandin H2 analogue (U46619) on human platelets by means of human granulocytic elastase and chymotrypsin. (1989) (8)
- Human Platelet Secreted Proteins and Prostacyclin Production by Bovine Aortic Endothelial Cells 1 2 (1983) (8)
- [The mechanism of fibrinolysis]. (1955) (8)
- Coagulation Disorders in Thrombocythaemia, a Study of Seven Cases (1962) (7)
- Rivanol in the Preparation of Plasminogen (Profibrinolysin) (1960) (7)
- Neutrophil-activating intercrine secreted by porcine platelets is active without proteolytic processing. (1993) (7)
- Potentiation of the thrombin induced platelet release reaction by fibrin. (1976) (7)
- Inhibition of proteolytic enzymes by β-lipoprotein (1966) (7)
- Fibrin Clot Retraction by Human Skin Fibroblasts: Effects of ADP and Thrombin 1 (1976) (7)
- Isolation and characterization of porcine platelets. (1989) (7)
- Blood clotting factors in cerebrospinal fluid (1962) (7)
- 3 – Platelet α-Granule Proteins: Biochemical and Pathological Aspects (1985) (7)
- [Adsorption of factors of the fibrinolytic system by bentonite]. (1959) (7)
- Neutralization of Antithrombin VI (Fibrinogen Breakdown Products) with Platelet Antiheparin Factor (Platelet Factor 4)* (1965) (7)
- [3] Isolation and characterization of porcine platelets (1989) (7)
- Binding of Dipyridamole of Human Platelets and to α-Acid Glycoprotein and its Significance for the Inhibition of Adenosine Uptake (1977) (7)
- The In-Vivo-Effect of E-Aminocaproic Acid (EACA) on Human Plasma Fibrinolytic System (1966) (7)
- Low Affinity Platelet Factor 4 and High Affinity Platelet Factor 4 - Two Antiheparin Factors Secreted by Human Platelets (1979) (7)
- New Evidence For An Adp-Independent Mechanism Of Thrombin Induced Platelet Activation (1981) (6)
- Fibrinolytic system of guinea pig serum. (1959) (6)
- [Biochemistry of hemostasis]. (1968) (6)
- Selective recognition of alpha2beta1 integrin by jararhagin, a Metalloproteinase/disintegrin from bBothrops jararaca venom. (2001) (6)
- Fibrinogen interaction with platelets of diabetic subjects. (1987) (6)
- Increased Levels of Low Affinity Platelet Factor 4 in Plasma and Urine of Patients With Chronic Renal Failure. (1979) (6)
- The antithrombin activity of glucuronic esters of bilirubin (1961) (6)
- Decrease of Platelet Aggregating Activity of Soluble Human Collagen Fractions during Ageing (1969) (5)
- A simple method of determining e-aminocaproic acid (eaca) in urine. (1965) (5)
- Purification and separation of platelet factor 2 (fibrinogen activating factor) and of platelet factor 4 (antiheparin factor). (1966) (5)
- Extracellular Signal-regulated Kinase (ERK) Activation Is Required for GP Ibα-dependent Endothelial Cell Migration (2001) (5)
- Inhibition of dog fibrinolytic system in experimental tubular necrosis of kidney (1964) (5)
- One-step affinity purification of recombinant alphavbeta3 integrin from transfected cells. (1996) (5)
- The release of platelet factor 4 during platelet aggregation and the possible significance of this reaction in hemostasis (1968) (5)
- Antiheparin Activity in Subcellular Fractions of Human Granulocytes (1969) (5)
- [A new anticoagulant derived from fibrinogen]. (1958) (5)
- Platelet aggregation by human collagen in relation to its age. (1967) (5)
- Low Affinity Platelet Factor 4 and High Affinity Platelet Factor 4 - Two Antiheparin Proteins Secreted by Human Platelets (1977) (5)
- PLATELET PROTECTION DURING CARDIOPULMONARY BYPASS with albumin prime and prostaglandins El infusion (1980) (5)
- [19] Platelet basic protein, low-affinity platelet factor 4, and β-Thromboglobulin: Purification and identification (1989) (4)
- Turnover of 131I-Fibrinogen in Mercury Chloride Intoxicated Dogs (1967) (4)
- Interaction of fibrin with various cells. (1973) (4)
- Platelet membrane components and receptors. (1987) (4)
- In Vitro Studies on the Mechanism of the Antifibrino-lytic Action of E-Aminocaproic Acid (EACA) (1968) (4)
- Adsorption of hageman factor (factor XII) on collagen (1964) (4)
- Membrane fluidity and platelet fibrinogen receptor exposure by proteolytic enzymes. (1985) (4)
- [Congenital afibrinogenemia. Biological study of 2 cases]. (1962) (4)
- Efficient flexible method for assay of human granulocyte elastase. (1995) (4)
- Effect of suloctidil [1(4-isopropylthiophenyl)-2-n-octylaminopropanol] on human platelets in vitro. (1979) (4)
- INTERACTION OF β3 INTEGRIN-DERIVED PEPTIDES 214–218 AND 217–231 WITH αIIbβ3 COMPLEX AND WITH FIBRINOGEN Aα-CHAIN (1997) (4)
- Release Of Platelet Factor-4 In Vivo After Heparin Injection (1981) (4)
- Fibrinogen receptor antagonists in cardiopulmonary bypass. (1993) (4)
- Electrophoretic pattern and reactivity of fibrinogen degradation products (FDP) in three assays. (2009) (4)
- Platelet interactions. (1978) (4)
- Method for Determining ε-Aminocaproic Acid (EACA) in Blood Plasma, Based on the Antifibrinolytic Properties of this Compound (1963) (3)
- Report of the working party on platelets. Platelet factor 4 (PF4), Platelet protein with heparin neutralizing activity. (1976) (3)
- Identification of human platelet membrane fibrinogen receptors by immunochemical techniques. (1984) (3)
- Serum-aldolase and serum-transaminases in trichinosis. (1960) (3)
- Evaluation of Recombinant Platelet Factor 4 and Protamine Sulfate for Heparin Neutralization: Clotting and Clearance Studies in Rat (1994) (3)
- Extracellular signal-regulated kinase (ERK) activation is required for GP Ibalpha-dependent endothelial cell migration. (2001) (3)
- Proceedings: Effect of ADP and thrombin on fibrin retraction induced by human platelets and fibroblasts. (1975) (3)
- Effect of zinc on the interaction between fibrinogen and platelet glycoprotein IIb/IIIa (GPIIb/IIIa) (1991) (3)
- Letter: Comments of the activation of Hageman factor (factor XII) by collagen. (1976) (3)
- Separation of the 100-kDa membrane protein mediating ADP-induced platelet shape change and activation from glycoprotein IIIa. (1986) (2)
- Effect of kidney elimination on fibrinolysis and clotting factors in dog blood plasma. (1965) (2)
- Human Platelet-Secreted Proteins (LA-PF4, βTG) Do Not Modify Prostacyclin (PGI2) Production By Bovine Aortic Endothelial Cells (1981) (2)
- Polymorphism of Platelet Secretory Proteins and Their Mitogenic Activity (1979) (2)
- Blood coagulation factors (2019) (2)
- Platelet aggregation by lathyric collagen. (1969) (2)
- Polish physicians under martial law. (1983) (2)
- Platelet basic protein, low-affinity platelet factor 4, and beta-thromboglobulin: purification and identification. (1989) (2)
- Desintegrins : a family of integrin inhibitory proteins from viper venoms(43129B) (1990) (2)
- Interaction of the Hageman factor (factor XII) with insoluble collagen. (1969) (2)
- The in vivo effect of the collagen of kaolin-activated contact factor on blood clotting and fibrinolysis in rabbit. (1967) (2)
- Beta 3 integrin derived peptide 217-230 inhibits fibrinogen binding and platelet aggregation: significance of RGD sequences and fibrinogen A alpha-chain. (1993) (2)
- Fibrinolytic system in the dog with experimental renal (goldblatt) hypertension (1967) (2)
- Distribution of procoagulant activity in the subcellular fractions of human granulocytes (1969) (2)
- CHARACTERIZATION OF FIBRINOGEN RECEPTORS ASSOCIATED WITH GLTCCPROIEIN IIb/IIIa (GPIIb/GPIIIa) COMPLEX BY TRIGRAMIN, A UNIQUE LOW MOLECULAR WEIGHT PEPTIDE PROBE (1987) (2)
- Fibrinolytic treatment of acute or subacute arterial thrombosis. (1976) (2)
- [Studies on hemophilia in Poland. II. AHG & Christmas factor deficiency with prolonged bleeding time (vascular hemophilia A & B)]. (1959) (1)
- Platelet thromboxane A2/prostaglandin H2 receptors in human volunteers on low doses of aspirin. (1990) (1)
- SELECTIVE INHIBITION OF HUMAN MEGAKARYOCYTOPOIESIS IN VITRO BY HIGHLY PURIFIED PLATELET FACTOR 4 (1987) (1)
- Influence of cytostatic agents on fibrinolytic and proteolytic enzymes and on phagocytosis of guinea-pig leucocytes (1967) (1)
- [Studies of the role of fibrinolysis in the pathogenesis of hemorrhagic diathesis]. (1961) (1)
- The effect of mercury chloride intoxication on the intracellular distribution of plasminogen activator in dog kidney tissue. (1968) (1)
- An improved method for separation of neutrophils from human blood using methylcellulose. (1995) (1)
- Hypercoagulability and thrombocytopenia after platelet factor 4 infusion into rabbits (1968) (1)
- Clotting of plasma with congenital blood coagulation factors deficiency by staphylocoagulase. (1965) (1)
- Influence of Plasmin on the Clotting and Anticlearing Activities of Platelets (1963) (1)
- [Plasminogen and plasmin. I. Studies on activation of plasminogen and on inactivation of plasmin]. (1956) (1)
- Platelet Aggregation and Release Triggered by Antibody to Platelet Factor 4 (PF4) 1 (1974) (1)
- Interaction of disintegrins with the llbf3 receptor on resting and activated human platelets (2005) (1)
- Comparative studies on the properties of human plasma and granulocyte plasminogens. (1968) (1)
- On the Relationship Between Low Affinity PF4 and ß-Thromboglobulin (1979) (1)
- [Appearance of antithrombin during proteolysis of fibrinogen]. (1957) (1)
- Purification and Properties of a Low Molecular Weight Protein from Human Platelets and its Relationship to Beta-Thromboglobulin (1979) (1)
- Evaluation of the histochemical method for studying the fibrinolytic activities of tissue sections. (1966) (1)
- Detection Of High Affinity Fibrinogen Binding Sites On Human Platelets Stimulated By ADP: Comparison Of Two Methods Of Platelet Separation (1981) (1)
- Relation Of Heparin Binding And Conformation In PF4 AND LA-PF4 (βTG) (1981) (1)
- Investigation on the mechanism of radioprotective action of EACA. (1966) (1)
- Partial Inactivation of Angiotensin II by Plasmin (1969) (1)
- Mitogenic activity of platelet secretory proteins (1979) (1)
- Elevation of serum aldolase and transaminases level in the course of trichinellosis. (1960) (1)
- Antiheparin proteins secreted by human platelets. Purification, characterization, and radioimmunoassay. [/sup 125/I tracer techniques] (1979) (1)
- Molecular changes during the activation of coagulation factor V by snake venom proteases (1983) (1)
- Modifications of Platelets that Affect Platelet Adherence to Collagen or Damaged Aorta aud Platelet Survival (1975) (1)
- [Appearance of an inhibitor of thromboplastin formation during proteolysis of fibrinogen]. (1959) (1)
- activation Structural requirements of platelet chemokines for neutrophil (2011) (0)
- Polish crackdown. (1982) (0)
- [Plasminogen and plasmin. II. Effect of metal ions on action of plasmin]. (1956) (0)
- [Antiproteolytic action of blood plasma and of its serum]. (1953) (0)
- [Enzymatologic aspects of the mechanism of action of sulfonamides and antibiotics]. (1950) (0)
- beta-thromboglobulin by limited proteolysis focusing. Evidence that low-affinity platelet factor 4 is converted to Identification and separation of secreted platelet proteins by isoelectric (2012) (0)
- Effects of U46619 on human platelets: dissociation of shape change from fibrinogen receptor exposure (1986) (0)
- [Not Available]. (1956) (0)
- [Clinical conditions precipitating the appearance of thrombosis]. (1965) (0)
- Characterization of an antibody raised against reduced glycoprotein IIIa of human platelets. (1991) (0)
- [Failures in the clinical use of coagulen]. (1958) (0)
- [Adsorption of thrombin by particles of silica]. (1959) (0)
- [Proteolytic enzymes of blood serum and their inhibitors]. (1952) (0)
- RADIOPROTECTIVE EFFECT OF AMINOCAPROIC ACID AND OF PANCREATIC TRYPSIN INHIBITOR IN RAT (1964) (0)
- Clotting factors of the primary aqueous humor of the rabbit's eye (1967) (0)
- PRODUCTS OF LIMITED PROTEOLYSIS OF GLYCOPROTEIN Ilia ON TEE PLATELET MEMBRANES (1987) (0)
- Fibrinolytic System in Hypotensive Patients; with a Special Reference to the Effect of Epsilon-Amino Caproic Acid (EACA) (1967) (0)
- STRUCTURE AND FUNCTIONAL PROPERTIES OF A FIBRINOGEN EERIVATIVE FORMED BY LIMITED PROTEOLYSIS WITH RED BLOOD CELL (1987) (0)
- [Comparative studies on fibrinolytic systems of human, ox and guinea pig sera]. (1959) (0)
- [Proteolytic activity of bile]. (1951) (0)
- DEVELOPMENT OF A RADIOIMMDNOASSAY PLATELET FACTOR 4 (1977) (0)
- [Role of plasma fibrinolytic system in the pathogenesis of human arterial hypertension and hypotension]. (1967) (0)
- [Behavior of serum aldolase and transaminase activity in trichinosis; preliminary communication]. (1958) (0)
- The aminotransferase system in pig-heart tissue. (1965) (0)
- [CONGENITAL AFIBRINOGENEMIA ACCORDING TO OUR OBSERVATIONS]. (1963) (0)
- [Transformation of glutamic acid and its clinical significance]. (1951) (0)
- Bez granic - naboj, ktorego dotad nie bylo (2000) (0)
- Platelet Interaction with Tumor Cells (1975) (0)
- [Pathogenesis of congenital hemorrhagic diatheses in the light of current concepts on blood coagulation and hemostasis]. (1965) (0)
- [Effect of a recently discovered anticoagulant antithrombin VI on blood coagulation. Preliminary communication]. (1959) (0)
- [Clinical significance of fibrinolysis]. (1955) (0)
- High Molecular Weight Kininogen Inhibits Fibrinogen Binding to Cytoadhesins of Neutrophfls and Platelets (2002) (0)
- Platelet aggregation by lathyric collagen. (1969) (0)
- [Fibrinolytic activity of the blood plasma in normal subjects]. (1956) (0)
- [Effect of experimental intestinal obstruction on coagulability of peripheral venous and portal blood in the dog]. (1968) (0)
- Contents, Vol. 13, 1967 (1967) (0)
- [Effect of bile on action of trypsin]. (1953) (0)
- Polish Crackdown (1982) (0)
- [Effect of various drugs on platelet aggregation and liberation of platelet factor 4 (anti-heparin factor)]. (1969) (0)
- [The biochemistry of fibrinolytic system of blood serum]. (1968) (0)
- [New concepts of synthesis biosynthesis of proteins]. (1953) (0)
- [Coagulation and fibrinolysis following shock due to transfusion of heterogenic blood]. (1954) (0)
- factor 4 Effect of heparin on the in vivo release and clearance of human platelet (2011) (0)
- [INHIBITORS OF FIBRINOLYSIS IN THE TREATMENT OF HEMORRHAGE, HEMORRHAGIC DIATHESIS AND SOME OTHER PATHOLOGICAL CONDITIONS. II. INHIBITORS OF PROTEOLYSIS AND FIBRINOLYSIS]. (1964) (0)
- Disintegrins and glycoprotein Ib binding proteins from viper venoms (1997) (0)
- RELATION BETWEEN PLASMA FIBRINOGEN LEVEL AND EUGLOBULIN LYSIS TIME Lysis Time in Minutes Fibrinogen (0)
- [Pathogenesis of thrombosis]. (1965) (0)
- [Studies on the mechanism of the radiation protective effect of proteolytic enzymes]. (1967) (0)
- [Interactions of blood platelets and erythrocytes with fibrinogen and fibrin]. (1978) (0)
- rhesus monkey (Macaca mulatta) In vivo release and turnover of secreted platelet antiheparin proteins in (2011) (0)
- Effect of experimental ileus on blood coagulability of peripheral venous and portal blood in dogs. (1969) (0)
- New tests for the diagnosis of consumption coagulopathy. (1969) (0)
- Blood clotting factors in cerebrospinal fluid 90 Factor V in cerebrospinal fluid (0)
- Interaction of beta 3 integrin-derived peptides 214-218 and 217-231 with alpha IIb beta 3 complex and with fibrinogen A alpha-chain. (1997) (0)
- [Studies on hemophilia in Poland. I. Results of clinical & laboratory tests in 111 cases]. (1958) (0)
- Untitled (2018) (0)
- Heparin Induced Release of Low Affinity Platelet Factor Four (1979) (0)
- [Activation of plasminogen in clotting euglobulins]. (1953) (0)
- [Mechanism of action of sulfonamides and antibiotics in the light of enzymology]. (1950) (0)
- [Studies on the mechanism of heparin action on blood clotting and fibrinolysis]. (1961) (0)
- [Increase of protein hydrolysis products during fibrinolysis]. (1952) (0)
- endoperoxide analogues Platelet aggregation and exposure of fibrinogen receptors by prostaglandin (2011) (0)
- Studies on the localization of fibrinogen binding sites on platelet glycoprotein IIIa. (1990) (0)
- Interaction of Thrombocytin with Platelets and Plasma Clotting Factors (1979) (0)
- Inhibition of proteolytic enzymes by beta-lipoprotein. (1966) (0)
- Effect of ADP and Thrombin on Fibrin Retraction Inducde by Human Platelets and Fibro-Blasts (1975) (0)
- In Memoriam Clive M. McCay (1967) (0)
- Index rerum ad Vol. 13 (1963) (0)
- [AN EPSILON-AMINOCAPROIC ACID PREPARATION AND ITS USE IN THE TREATMENT OF HEMORRHAGE AND HEMORRHAGIC DIATHESIS]. (1964) (0)
- INTERACTION OF PLATELET FACTOR 4 WITH HEPATOCYTES AND ITS POSSIBLE SIGNIFICANCE IN HEMOSTASIS (1987) (0)
- A natural motif approach to protein folding and design [1] (2002) (0)
- [Dr. Maksymilian ROSENMANN (1889-1960); in memoriam]. (1961) (0)
- phosphorylation glycoprotein IIb-IIIa in a patient with impaired pleckstrin Abnormal inside-out signal transduction-dependent activation of (2011) (0)
- Polish scientist not interned. (1982) (0)
- proteins from rat circulation Role of kidney in the catabolic clearance of human platelet antiheparin (2011) (0)
- [Not Available]. (1958) (0)
- Fibrinolytic system, fibrinogen degradation products and soluble fibrin monomer complexes of renal venous and aortal blood (1969) (0)
- [Disorders of hemostatic function of blood platelets in experimental trichomoniasis and vitamin C deficiency in guinea pigs]. (1969) (0)
- A memorial to Gwendolyn J. Stewart, Ph.D. (November 12, 1926--August 22, 1994). (1995) (0)
- Thrombocytin, A Novel Platelet Activating Enzyme from Bothrops Atrox (MARAJOENSIS) Venom (1977) (0)
- Effects of Infused Products of Tissue Injury on Generation of Circulating Fibrin Monomer, Condition of the Endothelium and Deposition of Blood Elements on Jugular Veins in the Dog (1977) (0)
- [Case of hemorrhagic diathesis due to the lack of factor VII..]. (1954) (0)
- Requirement Of Fibrinogen And Calcium For Inter-Platelet Bridges In Platelet Aggregation: A Hypothesis (1981) (0)
- [Behavior of glutamic-acetic and racemic acid transaminase and aldolase during the course of infectious hepatitis]. (1960) (0)
- [INHIBITORS OF FIBRINOLYSIS IN THE TREATMENT OF HEMORRHAGE, HEMORRHAGIC DIATHESIS AND SOME OTHER PATHOLOGICAL CONDITIONS. I. SPECIFIC INHIBITORS OF FIBRINOLYSIS]. (1964) (0)
- Elevation of serum aldolase (SA), serum glutamylooxaloacetic transaminase (SCOT) and serum glutamylopyruvic transaminase (SGPT) level in the course of trichinellosis. (1962) (0)
- [Biochemistry of preserved blood. IV. Enzymes]. (1953) (0)
- Possible Influence of Glycocalyx on Physical Properties of the Platelet Plasma Membrane. (1979) (0)
- [Effect of plasmin on the blood coagulation system; history of investigations on fibrinolysis]. (1959) (0)
- Stimulation Of DNA Synthesis In Mouse Fibroblasts By Purified Porcine Platelet Secreted Proteins (1981) (0)
- [Effect of plasmin and of streptokinase on blood coagulation in cat in vivo]. (1957) (0)
- [A new inhibitor of thromboplastin generation produced during the proteolytic degradation of fibrinogen]. (1959) (0)
- [Mechanism of action of enzymes]. (1958) (0)
- [Current views on the pathogenesis, therapy and prevention of hemophilias and related hemorrhagic diatheses]. (1961) (0)
- D. Platelet Factor 4 (PF4) - Platelet Protein with Heparin Neutralizing Activity (1976) (0)
- [Problem of the mechanism of activation of fibrinolytic processes following shock consecutive to transfusion of heterogenic blood]. (1956) (0)
- [Synthesis and action of streptokinase]. (1953) (0)
- FIBRINOGEN BINDS TO HUMAN NEUTROPHILS AT A SITE DISTINCT FROM GPIIb/IIIa (1987) (0)
- Biochemistry of blood platelets : colloquium held on occasion of the third meeting of the Federation of European Biochemical Societies, organized by the Polish Biochemical Society, Warszawa, April 4th-7th, 1966 (1967) (0)
- Binding of (14C) Dipyradamole (RA 8) to Platelets and Inhibition of ADP Induced Platelet Aggregation (1975) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Stefan Niewiarowski?
Stefan Niewiarowski is affiliated with the following schools:
